E
AREV Life Sciences Global Corp. AREV
CNSX
Recommendation
Sell
Prev Close
$0.09
Volume
--
Avg Vol (90D)
0
Market Cap
$2.08M
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
-$0.0055
My Lists My Alerts
Report
Weiss Ratings AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Rating E
Reward Index Very Weak
Risk Index Very Weak
Risk Grade E+
Reward Grade E
Rating Factors AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Dividend Index --
Growth Index Weak
Efficiency Index Very Weak
Solvency Index Very Weak
Total Return Index Weak
Volatility Index Weak
Beta / Standard Deviation AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Beta -0.14
Price History AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
7-Day Total Return 0.00%
30-Day Total Return 0.00%
60-Day Total Return 0.00%
90-Day Total Return 0.00%
Year to Date Total Return 0.00%
1-Year Total Return -47.06%
2-Year Total Return -59.09%
3-Year Total Return -62.50%
5-Year Total Return -91.43%
52-Week High % Change --
52-Week Low % Change --
Price AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
52-Week High Price --
52-Week Low Price --
52-Week Low Price (Date) Apr 19, 2024
52-Week High Price (Date) Apr 19, 2024
Valuation AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Market Cap 2.08M
Enterprise Value 2.19M
Price/Earnings (TTM) --
Earnings Per Share (TTM) -0.01
Earnings Per Share Growth -124.34%
Price/Earnings To Growth --
Price/Sales (TTM) 900.00
Price/Book (Q) -3.32
Enterprise Value/Revenue (TTM) 414.24
Price $0.09
Enterprise Value/EBITDA (TTM) -21.61
Enterprise Value/EBIT -15.15
Market Cap Category Nano Cap
Dividends and Shares AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Shares Outstanding 31.76M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) --
Dividend Per Share (Most Recent) --
Company Info AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Phone Number 604 803 8439
Address 18 - 91 Golden Drive Coquitlam, BC V3K 6R2
Website www.arevlifesciences.com
Country Canada
Year Founded --
Profitability AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Operating Margin (TTM) -2,733.96%
Profit Margin -3,360.37%
Management Effectiveness AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Return on Assets -43.07%
Return on Equity --
Income Statement AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Revenue (TTM) 5.30K
Total Revenue (TTM) 5.30K
Revenue Per Share $0.00
Gross Profit (TTM) -9.40K
EBITDA (TTM) -101.60K
EBIT (TTM) -144.90K
Net Income (TTM) -178.10K
Net Income Avl. to Common (TTM) -178.10K
Total Revenue Growth (Q YOY) --
Earnings Growth (Q YOY) 88.29%
EPS Diluted (TTM) -0.01
EPS Diluted Growth (Q YOY) 88.33%
Balance Sheet AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash and Short-Term Inv. (Q) 1.30K
Cash Per Share (Q) $0.00
Total Current Assets (Q) 50.90K
Total Preferred Equity (Q) --
Total Equity (Q) -859.80K
Current Ratio (Q) 0.050
Book Value Per Share (Q) -$0.03
Total Assets (Q) 157.70K
Total Current Liabilities (Q) 1.02M
Total Debt (Q) 107.50K
Total Liabilities (Q) 1.02M
Total Common Equity (Q) -859.80K
Cash Flow AREV - CNSX Click to
Compare		 Click to
Compare		 Click to
Compare
Cash from Investing (TTM) -1.10K
Cash from Financing (TTM) 103.70K
Net Change in Cash (TTM) -10.00K
Levered Free Cash Flow (TTM) -61.50K
Cash from Operations (TTM) -112.60K
Weiss Ratings